ANNA MALOVANNAYA to Myeloproliferative Disorders
This is a "connection" page, showing publications ANNA MALOVANNAYA has written about Myeloproliferative Disorders.
Connection Strength
0.206
-
Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML. Blood. 2025 02 06; 145(6):612-624.
Score: 0.206
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.